cysteine has been researched along with tacrolimus in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 12 (57.14) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Broekelmann, TJ; Davis, EC; Mecham, RP; Ozawa, Y | 1 |
| Kudla, J; Liang, S; Luan, S; Xu, Q | 1 |
| Florio, G; Marone, G; Patella, V; Petraroli, A; Triggiani, M | 1 |
| Hueni, SE; Lash, LH; Putt, DA | 1 |
| Blackmore, M; Gray, TJ; Lock, EA; Morton, JK; Whitwell, C | 1 |
| Alphey, MS; Coombs, GH; Hunter, WN; Mottram, JC; Williams, RA | 1 |
| Fukushima, C; Kawano, T; Kohno, S; Kondo, Y; Machida, I; Matsuse, H; Obase, Y; Saeki, S; Tomari, S | 1 |
| Mimori, T; Yukawa, N | 1 |
| Kawai, S; Miyasaka, N; Takeuchi, T; Tanaka, Y; Yamamoto, K | 1 |
| Gallego, D; Gil, V; Jiménez, M | 1 |
| Amano, H; Kageyama, M; Kempe, K; Kusaoi, M; Matsudaira, R; Matsushita, M; Morimoto, S; Nawata, M; Ogasawara, M; Onuma, S; Sekiya, F; Tada, K; Takasaki, Y; Tamura, N; Toyama, S; Yamaji, K | 1 |
| Ichikawa, N; Yamanaka, H | 1 |
| Tamura, N | 1 |
| Du, ZX; Hao, AJ; Ling, EA; Liu, DX; Wang, FW; Wang, Z; Yuan, QH; Zhan, JM; Zhang, Q | 1 |
| Tanaka, E; Yamanaka, H | 1 |
| Guo, J; Huang, D; Li, J; Liu, C; Lu, X; Wang, H; Xiao, A; Xu, T; Zhu, J | 1 |
| Ito, S | 1 |
| Futase, A; Honda, H; Shimizu, S; Ueda, S; Yokoyama, T | 1 |
| Futase, A; Honda, H; Shimizu, S; Yokoyama, T | 1 |
| Chang, D; Dai, J; Gao, H; Meng, L; Pan, H; Rong, S; Yu, H; Zhang, Y; Zhang, Z | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
5 review(s) available for cysteine and tacrolimus
| Article | Year |
|---|---|
[Effect of disease modifying anti-rheumatic drugs on radiographic progression in rheumatoid arthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Cysteine; Disease Progression; Drug Therapy, Combination; Gold Sodium Thiomalate; Humans; Isoxazoles; Leflunomide; Methotrexate; Penicillamine; Radiography; Randomized Controlled Trials as Topic; Sulfasalazine; Tacrolimus | 2009 |
[ Bone and cartilage destruction in RA and its intervention. Disease-modifying antirheumatic drugs].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Bone and Bones; Cartilage; Clinical Trials as Topic; Cysteine; Humans; Isoxazoles; Joints; Leflunomide; Methotrexate; Sulfasalazine; Tacrolimus | 2012 |
[DMARDs (disease-modifying antirheumatic drugs)].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Humans; Japan; Methotrexate; Sulfasalazine; Tacrolimus | 2013 |
[DMARDs (Focusing on iguratimod)].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Chromones; Cysteine; Drug Discovery; Drug Interactions; Drug Substitution; Drug Therapy, Combination; Drugs, Generic; Female; Humans; Male; Ribonucleosides; Sulfasalazine; Sulfonamides; Tacrolimus | 2016 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for cysteine and tacrolimus
| Article | Year |
|---|---|
Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs--a multicenter, double-blind, parallel-group trial.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Joints; Male; Methotrexate; Middle Aged; Severity of Illness Index; Sulfasalazine; Tacrolimus; Treatment Outcome | 2011 |
15 other study(ies) available for cysteine and tacrolimus
| Article | Year |
|---|---|
Identification of tropoelastin as a ligand for the 65-kD FK506-binding protein, FKBP65, in the secretory pathway.
Topics: Amino Acid Isomerases; Animals; Brefeldin A; Carrier Proteins; Cattle; Cell Compartmentation; Centrifugation, Density Gradient; Cyclopentanes; Cysteine; DNA-Binding Proteins; Heat-Shock Proteins; Leupeptins; Ligands; Methionine; Molecular Weight; Protein Folding; Protein Synthesis Inhibitors; Tacrolimus; Tacrolimus Binding Proteins; Tropoelastin | 1998 |
Molecular characterization of a plant FKBP12 that does not mediate action of FK506 and rapamycin.
Topics: Amino Acid Sequence; Calcineurin; Cloning, Molecular; Cysteine; Disulfides; Dithiothreitol; Fabaceae; Genes, Plant; Genetic Complementation Test; Immunophilins; Immunosuppressive Agents; Molecular Sequence Data; Mutation; Plants, Medicinal; Protein Binding; Protein Structure, Tertiary; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Sirolimus; Sulfhydryl Reagents; Tacrolimus; Tacrolimus Binding Proteins | 1998 |
The immunoglobulin superantigen-binding site of HIV-1 gp120 activates human basophils.
Topics: Adult; Amino Acid Sequence; Antibodies, Anti-Idiotypic; Basophils; Binding Sites, Antibody; Cyclosporine; Cysteine; Histamine Release; HIV Envelope Protein gp120; HIV-1; HIV-2; Humans; Immunoglobulin E; Immunoglobulin M; Immunosuppressive Agents; Inflammation Mediators; Interleukin-4; Kinetics; Leukotriene C4; Leukotrienes; Molecular Sequence Data; Peptides; Receptors, IgE; Superantigens; Tacrolimus | 2000 |
Apoptosis, necrosis, and cell proliferation induced by S-(1,2-dichlorovinyl)-L-cysteine in primary cultures of human proximal tubular cells.
Topics: Adult; Aged; Annexin A5; Apoptosis; Caspases; Cell Cycle; Cell Division; Cell Survival; Cells, Cultured; Cysteine; DNA; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Kidney Tubules, Proximal; L-Lactate Dehydrogenase; Male; Methimazole; Microscopy, Confocal; Middle Aged; Necrosis; Tacrolimus; Time Factors | 2001 |
The effects of haloalkene cysteine conjugates on cytosolic free calcium levels in LLC-PK(1) cells--studies utilising digital imaging fluorescence microscopy.
Topics: Aminooxyacetic Acid; Animals; Butadienes; Calcium; Cysteine; Cytosol; Egtazic Acid; Enzyme Inhibitors; Fluorescent Dyes; Fura-2; Homocysteine; Image Processing, Computer-Assisted; L-Lactate Dehydrogenase; LLC-PK1 Cells; Microscopy, Fluorescence; Swine; Tacrolimus | 2002 |
The crystal structure of Leishmania major 3-mercaptopyruvate sulfurtransferase. A three-domain architecture with a serine protease-like triad at the active site.
Topics: Amino Acid Sequence; Animals; Binding Sites; Catalysis; Catalytic Domain; Cattle; Crystallography, X-Ray; Cysteine; Dose-Response Relationship, Drug; Hydrolysis; Immunosuppressive Agents; Leishmania major; Models, Chemical; Models, Molecular; Molecular Sequence Data; Protein Conformation; Protein Folding; Protein Structure, Secondary; Protein Structure, Tertiary; Serine Endopeptidases; Sulfurtransferases; Tacrolimus; Thiosulfate Sulfurtransferase | 2003 |
Effects of antiasthmatic agents on the functions of peripheral blood monocyte-derived dendritic cells from atopic patients.
Topics: Adrenal Cortex Hormones; Adult; Anti-Asthmatic Agents; Antigens, Dermatophagoides; CD4-Positive T-Lymphocytes; Cell Differentiation; Cysteine; Cytokines; Dendritic Cells; Female; Humans; Hypersensitivity, Immediate; Leukotriene Antagonists; Leukotrienes; Male; Monocytes; Tacrolimus | 2004 |
Effects of inhibitors of hydrogen sulphide synthesis on rat colonic motility.
Topics: Alkynes; Animals; Colon; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Cysteine; Enzyme Inhibitors; Gastrointestinal Motility; Gastrointestinal Tract; Glycine; Hydrogen Sulfide; Hydroxylamine; Male; Membrane Potentials; Muscle, Smooth; Nitric Oxide; Rats; Rats, Sprague-Dawley; Tacrolimus; Tetrodotoxin | 2011 |
Single-center, retrospective analysis of efficacy and safety of tacrolimus as a second-line DMARD in combination therapy and the risk factors contributing to adverse events in 115 patients with rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Disease Progression; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Severity of Illness Index; Sulfasalazine; Tacrolimus; Treatment Outcome | 2012 |
[Rheumatoid arthritis: progress in diagnosis and treatment. Topics: IV. Treatment; 2. Antirheumatic agents, 1) non-biologic agents].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Female; Humans; Methotrexate; Sulfasalazine; Tacrolimus | 2012 |
L-Cysteine promotes the proliferation and differentiation of neural stem cells via the CBS/H₂S pathway.
Topics: Analysis of Variance; Animals; Bromodeoxyuridine; Cell Differentiation; Cell Proliferation; Cell Survival; Cystathionine beta-Synthase; Cysteine; Dose-Response Relationship, Drug; Embryo, Mammalian; Flow Cytometry; Gene Expression Regulation; Hydrogen Sulfide; Mice; Nerve Tissue Proteins; Neural Stem Cells; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Tacrolimus; Telencephalon; Time Factors; Transcription Factors | 2013 |
H2S, a novel gasotransmitter, involves in gastric accommodation.
Topics: Animals; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Cysteine; Dyspepsia; Eating; Electric Stimulation; Gasotransmitters; Gastric Fundus; Gastric Mucosa; Guanidines; Humans; Hydrogen Sulfide; Male; Mice; Mice, Inbred BALB C; Mice, Transgenic; Microscopy, Fluorescence; Muscle Contraction; Pyridoxal; Signal Transduction; Stomach; Substrate Specificity; Sulfides; Tacrolimus | 2015 |
Reduction of FR900525 using an S-(2-aminoethyl) l-cysteine-resistant mutant.
Topics: Cysteine; Mutation; Oxidation-Reduction; Streptomyces; Tacrolimus; Ultraviolet Rays | 2017 |
Genomic analysis of a Streptomyces tsukubaensis mutant with reduced FR900525 production isolated by selection for S-(2-aminoethyl) l-cysteine resistance.
Topics: Cysteine; Drug Resistance; Gene Expression Regulation, Bacterial; Genome, Bacterial; Genomics; Immunosuppressive Agents; Macrolides; Organisms, Genetically Modified; Streptomyces; Tacrolimus | 2018 |
Spherical carrier amplification strategy for electrochemical immunosensor based on polystyrene-gold nanorods @L-cysteine/MoS
Topics: Antibodies, Immobilized; Biosensing Techniques; Cysteine; Electrochemical Techniques; Gold; Immunoassay; Limit of Detection; Metal Nanoparticles; Molybdenum; Nanotubes; Polystyrenes; Tacrolimus | 2020 |